Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Human CRADD Protein

<strong>Human CRADD Protein</strong>_x000D_ <strong>Catalog number:</strong> B2012021_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 100 µg_x000D_ <strong>Molecular Weight or Concentration:</strong> 1 mg/mL_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20 °C_x000D_ <strong>Keywords:</strong> RIP associated ICH1/CED3 homologous protein with death domain protein, Caspase and RIP adapter with death domain protein, CRADD protein, MGC9163 protein, Caspase and RIP adapter with death domain CASP2 and RIPK1 domain containing adaptor with death domain_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Cohen GM. Caspases: the executioners of apoptosis Biochem J. 1997 Aug 15;326 ( Pt 1)(Pt 1):1-16._x000D_ 2: Li W, Wang L, Wu Y, Yuan Z, Zhou J. Weighted gene co‑expression network analysis to identify key modules and hub genes associated with atrial fibrillation Int J Mol Med. 2020 Feb;45(2):401-416._x000D_ 3: Ahmad M, Srinivasula SM, Wang L, Talanian RV, Litwack G, Fernandes-Alnemri T, Alnemri ES. CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/tumor necrosis factor receptor-interacting protein RIP Cancer Res. 1997 Feb 15;57(4):615-9._x000D_ 4: Di Donato N, Timms AE, Aldinger KA, Mirzaa GM, Bennett JT, Collins S, Olds C, Mei D, Chiari S, Carvill G, Myers CT, Rivière JB, Zaki MS; University of Washington Center for Mendelian Genomics, Gleeson JG, Rump A, Conti V, Parrini E, Ross ME, Ledbetter DH, Guerrini R, Dobyns WB. Analysis of 17 genes detects mutations in 81% of 811 patients with lissencephaly Genet Med. 2018 Nov;20(11):1354-1364._x000D_ 5: Sheikh TI, Vasli N, Pastore S, Kharizi K, Harripaul R, Fattahi Z, Pande S, Naeem F, Hussain A, Mir A, Islam O, Girisha KM, Irfan M, Ayub M, Schwarzer C, Najmabadi H, Shukla A, Sladky VC, Braun VZ, Garcia-Carpio I, Villunger A, Vincent JB. Biallelic mutations in the death domain of PIDD1 impair caspase-2 activation and are associated with intellectual disability Transl Psychiatry. 2021 Jan 5;11(1):1._x000D_ 6: Harel T, Hacohen N, Shaag A, Gomori M, Singer A, Elpeleg O, Meiner V. Homozygous null variant in CRADD, encoding an adaptor protein that mediates apoptosis, is associated with lissencephaly Am J Med Genet A. 2017 Sep;173(9):2539-2544._x000D_ 7: Zaki MS, Accogli A, Mirzaa G, Rahman F, Mohammed H, Porras-Hurtado GL, Efthymiou S, Maqbool S, Shukla A, Vincent JB, Hussain A, Mir A, Beetz C, Leubauer A, Houlden H, Gleeson JG, Maroofian R. Pathogenic variants in PIDD1 lead to an autosomal recessive neurodevelopmental disorder with pachygyria and psychiatric features Eur J Hum Genet. 2021 Aug;29(8):1226-1234._x000D_ 8: Qiao H, Liu Y, Veach RA, Wylezinski L, Hawiger J. The adaptor CRADD/RAIDD controls activation of endothelial cells by proinflammatory stimuli J Biol Chem. 2014 Aug 8;289(32):21973-83._x000D_ 9: Polla DL, Rahikkala E, Bode MK, Määttä T, Varilo T, Loman T, Philips AK, Kurki M, Palotie A, Körkkö J, Vieira P, Avela K, Jacquemin V, Pirson I, Abramowicz M, de Brouwer APM, Kuismin O, van Bokhoven H, Järvelä I. Phenotypic spectrum associated with a CRADD founder variant underlying frontotemporal predominant pachygyria in the Finnish population Eur J Hum Genet. 2019 Aug;27(8):1235-1243._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/27773430">10: Di Donato N, Jean YY, Maga AM, Krewson BD, Shupp AB, Avrutsky MI, Roy A, Collins S, Olds C, Willert RA, Czaja AM, Johnson R, Stover JA, Gottlieb S, Bartholdi D, Rauch A, Goldstein A, Boyd-Kyle V, Aldinger KA, Mirzaa GM, Nissen A, Brigatti KW, Puffenberger EG, Millen KJ, Strauss KA, Dobyns WB, Troy CM, Jinks RN. Mutations in CRADD Result in Reduced Caspase-2-Mediated Neuronal Apoptosis and Cause Megalencephaly with a Rare Lissencephaly Variant Am J Hum Genet. 2016 Nov 3;99(5):1117-1129. </a>_x000D_ _x000D_ <strong>Products Related to Human CRADD Protein can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>

Product Specifications

Short Description

Catalog Number: B2012021 (100 µg)

Weight

0.15

Length

2

Width

0.5

Height

0.5

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

E2F6 Peptide
MBS3225848-01 0.1 mg

E2F6 Peptide

Ask
View Details
E2F6 Peptide
MBS3225848-02 5x 0.1 mg

E2F6 Peptide

Ask
View Details
UNC3866
MBS579926 Inquire

UNC3866

Ask
View Details
Rabbit Polyclonal FoxH1 Antibody [PerCP]
NBP2-41196PCP 0.1 mL

Rabbit Polyclonal FoxH1 Antibody [PerCP]

Ask
View Details
Rabbit anti-Escherichia coli (strain 8739/DSM 1576/Crooks) CUTC Polyclonal Antibody
MBS7184283 Inquire

Rabbit anti-Escherichia coli (strain 8739/DSM 1576/Crooks) CUTC Polyclonal Antibody

Ask
View Details
FluoroQuest™ Mounting Medium with DAPI
20004-AAT 50 mL

FluoroQuest™ Mounting Medium with DAPI

Ask
View Details